首页> 外国专利> METHOD FOR IDENTIFYING NON-RESPONDERS TO FIRST LINE OF TUBERCULOSIS DRUG REGIME

METHOD FOR IDENTIFYING NON-RESPONDERS TO FIRST LINE OF TUBERCULOSIS DRUG REGIME

机译:识别结核病药物第一线无反应者的方法

摘要

The present invention provides a method for identifying non-responder to a first line of tuberculosis drug regime, which have a prospective risk of development of drug resistant tuberculosis (DR-TB) infection in plurality of subjects by using differential levels of RNA signatures therein. The method comprises identifying differential levels of RNA signatures by analysing RNA library; quantitatively analysing the detected small non-coding RNAs for identifying exhibited differential levels of RNA signatures in plurality of subjects, and creating expression profiles for plurality of subjects; comparing the expression profiles of the plurality of subjects to identify responders and non-responders based on the differential levels of the RNA signatures; and validating the expression profiles of the non-responders against the expression profiles of the responders for determining the prospective risk of development of drug resistant tuberculosis infection. Moreover, the present invention provides a diagnostic kit to be used with the aforementioned method.
机译:本发明提供了一种用于识别对第一线结核药物方案无反应的方法,该方法通过在其中使用不同水平的RNA特征在多个受试者中具有发展抗药性结核(DR-TB)感染的预期风险。该方法包括通过分析RNA文库鉴定不同水平的RNA标记;定量分析检测到的小非编码RNA,以鉴定多个受试者中RNA标记物的差异水平,并创建多个受试者的表达谱;比较多个受试者的表达谱,以基于RNA标记的差异水平鉴定应答者和非应答者;相对于应答者的表达概况验证非应答者的表达概况,以确定耐药性结核感染发展的预期风险。此外,本发明提供了一种用于上述方法的诊断试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号